Spots Global Cancer Trial Database for Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Official Title: Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Study ID: NCT05181826

Conditions

Interventions

Multi-analyte Blood Test

Study Description

Brief Summary: To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.

Detailed Description: Whole blood, plasma, and/or serum specimens will be collected from patients with active cancer, patients in cancer remission, patients diagnosed with benign disease, and healthy volunteers. These blood samples will be used to perform various studies to determine the utility of select DNA methylation markers for cancer diagnostic or prognostic indications.